Effects of anthrax lethal toxin on human primary keratinocytes

Journal of Applied Microbiology

Volumn 105, Issue 6, 2008, Pages 1756-1767

  Kocer S S ^a   Matic, M ^a   Ingrassia, M ^a   Walker, S G ^a   Roemer, E ^a   Licul, G ^a   Simon, S R ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Anthrax; Cutaneous; Keratinocytes; Lethal toxin; Proteasome; RANTES

Indexed keywords

BIOMARKERS; DISEASES; ENZYMES;

ANTHRAX; ANTI-INFLAMMATORY AGENTS; CUTANEOUS; CYTOKINES; INFLAMMATORY RESPONSE; KERATINOCYTES; LETHAL TOXIN; MITOGEN-ACTIVATED PROTEIN KINASE KINASE; PROTEASOMES; RANTES;

CYTOTOXICITY;

ANTHRAX LETHAL TOXIN; ANTHRAX TOXIN; CHEMOATTRACTANT; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE KINASE; RANTES; UNCLASSIFIED DRUG;

ANTHRAX; BIOMARKER; DEGRADATION; PROTEIN; SKIN; TOXICITY; TOXIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LEVEL; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; ENZYME DEGRADATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; KERATINOCYTE; NEUTROPHIL CHEMOTAXIS; PROTEIN EXPRESSION; SKIN INFECTION; UPREGULATION;

EID: 56649083653     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/j.1365-2672.2008.03806.x     Document Type: Article

References (39)

1. Baldari, C.T., Tonello, F., Paccani, S.R. Montecuco, C. (2006) Anthrax toxins: a paradigm of bacterial immune suppression. Trends Immunol 27, 434 440.
2. Bardwell, A.J., Abdollahi, M. Bardwell, L. (2004) Anthrax lethal factor-cleavage products of MAPK (mitogen-activated protein kinase) kinases exhibit reduced binding to their cognate MAPKs. Biochem J 378, 569 577.
3. Batty, S., Chow, E.M., Kassam, A., Der, S.D. Mogridge, J. (2006) Inhibition of mitogen-activated protein kinase signalling by Bacillus anthracis lethal toxin causes destabilization of interleukin-8 mRNA. Cell Microbiol 8, 130 138.
4. Bravata, D.M., Holty, J.E., Wang, E., Lewis, R., Wise, P.H., McDonald, K.M. Owens, D.K. (2007) Inhalational, gastrointestinal, and cutaneous anthrax in children. A systematic review of cases: 1900 to 2005. Arch Ped Adolesc Med 161, 896 905.
5. Casola, A., Burger, N., Liu, T., Jamaluddin, M., Brasier, A.R. Garofalo, R.P. (2001) Oxidant tone regulates RANTES gene expression in airway epithelial cells infected with respiratory syncytial virus. Role in viral-induced interferon regulatory factor activation. J Biol Chem 276, 19715 19722.
6. Centers for Disease Control and Prevention (2000) Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 49, 1 20.
7. Dauphinee, S.M. Karsan, A. (2006) Lipopolysaccharide signaling in endothelial cells. Lab Invest 86, 9 22.
8. Demirdag, K., Ozden, M., Saral, Y., Kalkan, A., Kilic, S.S. Ozdarendeli, A. (2003) Cutaneous anthrax in adults: a review of 25 cases in the eastern Anatolian region of Turkey. Infection 31, 327 330.
9. Dziarski, R. Gupta, D. (2006) Role of MD-2 in TLR2- and TLR4-mediated recognition of Gram-negative and Gram-positive bacteria and activation of chemokine genes. J Endotoxin Res 6, 401 405.
10. Erwin, J.L., DaSilva, L.M., Bavari, S., Little, S.F., Friedlander, A.M. Chanh, T.C. (2001) Macrophage-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin. Infect Immun 69, 1175 1177.
11. Godyn, J.J., Reyes, J., Siderits, R. Hazra, A. (2005) Cutaneous anthrax: conservative or surgical treatment. Adv Skin Wound Care 18, 146 150.
12. Ho, D.T., Bardwell, A.J., Abdollahi, M. Bardwell, L. (2003) A docking site in MKK4 mediates high affinity binding to JNK MAPKs and competes with similar docking sites in JNK substrates. J Biol Chem 278, 32662 32672.
13. Irmak, H., Buzgan, T., Karahocagil, M.K., Sakarya, N., Akdeniz, H., Caksen, H. Demiroz, P. (2003) Cutaneous manifestations of anthrax in Eastern Anatolia: a review of 39 cases. Acta Med Okayama 57, 235 240.
14. Karakas, H.M., Bayindir, Y., Firat, A.K., Yagmur, C., Alkan, A. Kayabas, U. (2006) Cerebral diffusional changes in the early phase of anthrax: is cutaneous anthrax only limited to skin? J Infect 52, 354 358.
15. Kim, S.O., Jing, Q., Hoebe, K., Beutler, B., Duesbery, N.S. Han, J. (2003) Sensitizing anthrax lethal toxin-resistant macrophages to lethal toxin-induced killing by tumor necrosis factor-alpha. J Biol Chem 278, 7413 7421.
16. Kirby, J.E. (2004) Anthrax lethal toxin induces human endothelial cell apoptosis. Infect Immun 72, 430 439.
17. Klimpel, K.R., Arora, N. Leppla, S.H. (1994) Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity. Mol Microbiol 13, 1093 1100.
18. Kocer, S.S. Simon, S.R. (2007) Effects of anthrax lethal toxin on human peripheral blood monocytes (in preparation).
19. Kocer, S.S., Walker, S.G, Zerler, B., Golub, L.M. Simon, S.R. (2005) Metalloproteinase inhibitors, non-antimicrobial chemically modified tetracyclines and Ilomastat, block Bacillus anthracis lethal factor activity in viable cells. Infect Immun 73, 7548 7557.
20. Kudo, T., Lu, H., Wu, J.Y., Graham, D.Y., Casola, A. Yamaoka, Y. (2005) Regulation of RANTES promoter activation in gastric epithelial cells infected with Helicobacter pylori. Infect Immun 73, 7602 7612.
21. Maguina, C., Flores Del Pozo, J., Terashima, A., Gotuzzo, E., Guerra, H., Vidal, J.E., Legua, P. Solari, L. (2005) Cutaneous anthrax in Lima, Peru: retrospective analysis of 71 cases, including four with a meningoencephalic complication. Rev Inst Med Trop de São Paulo 47, 25 30.
22. Matic, M., Evans, W.H., Brink, P.R. Simon, M. (2002) Epidermal stem cells do not communicate through gap junctions. J Invest Dermatol 118, 110 116.
23. Mayer-Scholl, A., Hurwitz, R., Brinkmann, V., Schmid, M., Jungblut, P., Weinrauch, Y. Zychlinsky, A. (2005) Human neutrophils kill Bacillus anthracis. Public Libr Sci Pathog 1, e23.
24. Mock, M. Fouet, A. (2001) Anthrax. Annu Rev Microbiol 55, 647 671.
25. Oncul, O., Ozsoy, M.F., Gul, H.C., Kocak, N., Cavuslu, S. Pahsa, A. (2002) Cutaneous anthrax in Turkey: a review of 32 cases. Scand J Infect Dis 34, 413 416.
26. Park, J.M., Greten, F.R., Li, Z.W. Karin, M. (2002) Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297, 2048 2051.
27. Pellizzari, R., Guidi-Rontani, C., Vitale, G., Mock, M. Montecucco, C. (1999) Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha. FEBS Lett 462, 199 204.
28. Popov, S.G., Villasmil, R., Bernardi, J., Grene, E., Cardwell, J., Popova, T., Wu, A., Alibek, D. et al. (2002a) Effect of Bacillus anthracis lethal toxin on human peripheral blood mononuclear cells. FEBS Lett 527, 211 215.
29. Popov, S.G., Villasmil, R., Bernardi, J., Grene, E., Cardwell, J., Wu, A., Alibek, D., Bailey, C. et al. (2002b) Lethal toxin of Bacillus anthracis causes apoptosis of macrophages. Biochem Biophys Res Commun 293, 349 355.
30. Roche, K.J., Chang, M.W. Lazarus, H. (2001) Images in clinical medicine. Cutaneous anthrax infection. New Engl J Med 345, 1611.
31. Shiferaw, G. (2004) Anthrax in Wabessa village in the Dessie Zuria district of Ethiopia. Sci Tech Rev 23, 951 956.
32. Squires, R.C., Muehlbauer, S.M. Brojatsch, J. (2007) Proteasomes control caspase-1 activation in anthrax lethal toxin-mediated cell killing. J Biol Chem 282, 34260 34267.
33. Tang, G. Leppla, S.H (1999) Proteasome activity is required for anthrax lethal toxin to kill macrophages. Infect Immun 67, 3055 3060.
34. Vijaikumar, M., Thappa, D.M. Jeevankumar, B. (2001) Cutaneous anthrax: still a reality in India. Pediatr Dermatol 18, 456 457.
35. Vitale, G., Bernardi, L., Napolitani, G., Mock, M. Montecucco, C. (2000) Susceptibility of mitogen-activated protein kinase family members to proteolysis by anthrax lethal factor. Biochem J 3, 739 745.
36. Wade, B.H., Wright, G.G., Hewlett, E.L., Leppla, S.H. Mandell, G.L. (1985) Anthrax toxin components stimulate chemotaxis of human polymorphonuclear neutrophils. Proc Soc Exp Biol Med 179, 159 162.
37. Watters, J.W., Dewar, K., Lehoczky, J., Boyartchuk, V. Dietrich, W.F. (2001) Kif1C, a kinesin-like motor protein, mediates mouse macrophage resistance to anthrax lethal factor. Curr Biol 11, 1503 1511.
38. Woods, C.W., Ospanov, K., Myrzabekov, A., Favorov, M., Plikaytis, B. Ashford, D.A. (2004) Ashford, risk factors for human anthrax among contacts of anthrax-infected livestock in Kazakhstan. Am J Trop Med Hyg 71, 48 52.
39. Yetkin, M.A., Erdinc, F.S., Bulut, C. Tulek, N. (2006) Cutaneous anthrax as an occupational disease in Central Anatolia, Turkey. Saudi Med J 27, 737 739.